FN1 and neoplasm: Our study demonstrates that treatment of MCF-7 cells with ATRA downregulates the expression of α5 and β1 which reflects the result of cell adhesion assay, showing reduced tumor cell binding to ECM protein fibronectin after ATRA treatment in a time dependent manner.